Hari, P., & Goldschmidt, H. (2017). Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes. Leukemia, 31(12), . https://doi.org/10.1038/leu.2017.122
Chicago-Zitierstil (17. Ausg.)Hari, Parameswaran, und Hartmut Goldschmidt. "Efficacy and Safety of Carfilzomib Regimens in Multiple Myeloma Patients Relapsing After Autologous Stem Cell Transplant: ASPIRE and ENDEAVOR Outcomes." Leukemia 31, no. 12 (2017). https://doi.org/10.1038/leu.2017.122.
MLA-Zitierstil (9. Ausg.)Hari, Parameswaran, und Hartmut Goldschmidt. "Efficacy and Safety of Carfilzomib Regimens in Multiple Myeloma Patients Relapsing After Autologous Stem Cell Transplant: ASPIRE and ENDEAVOR Outcomes." Leukemia, vol. 31, no. 12, 2017, https://doi.org/10.1038/leu.2017.122.